Dr Martens PLC
OTC:DRMTY
Balance Sheet
Balance Sheet Decomposition
Dr Martens PLC
Dr Martens PLC
Balance Sheet
Dr Martens PLC
| Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
86
|
58
|
117
|
114
|
228
|
158
|
111
|
156
|
|
| Cash Equivalents |
86
|
58
|
117
|
114
|
228
|
158
|
111
|
156
|
|
| Total Receivables |
37
|
49
|
65
|
56
|
88
|
86
|
63
|
61
|
|
| Accounts Receivables |
30
|
41
|
56
|
51
|
76
|
79
|
54
|
50
|
|
| Other Receivables |
7
|
8
|
10
|
5
|
12
|
8
|
9
|
11
|
|
| Inventory |
40
|
54
|
90
|
102
|
123
|
258
|
255
|
187
|
|
| Other Current Assets |
6
|
4
|
5
|
4
|
5
|
7
|
8
|
7
|
|
| Total Current Assets |
169
|
166
|
277
|
275
|
444
|
509
|
437
|
411
|
|
| PP&E Net |
24
|
27
|
115
|
110
|
144
|
205
|
233
|
193
|
|
| PP&E Gross |
24
|
27
|
115
|
110
|
144
|
205
|
233
|
193
|
|
| Accumulated Depreciation |
13
|
21
|
45
|
72
|
95
|
139
|
184
|
230
|
|
| Intangible Assets |
8
|
11
|
17
|
20
|
21
|
25
|
29
|
33
|
|
| Goodwill |
241
|
241
|
241
|
241
|
241
|
241
|
241
|
241
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Long-Term Assets |
4
|
6
|
7
|
7
|
10
|
13
|
11
|
11
|
|
| Other Assets |
241
|
241
|
241
|
241
|
241
|
241
|
241
|
241
|
|
| Total Assets |
446
N/A
|
450
+1%
|
657
+46%
|
653
-1%
|
859
+32%
|
993
+16%
|
952
-4%
|
890
-7%
|
|
| Liabilities | |||||||||
| Accounts Payable |
20
|
20
|
33
|
53
|
52
|
64
|
125
|
136
|
|
| Accrued Liabilities |
22
|
28
|
50
|
75
|
77
|
58
|
60
|
77
|
|
| Short-Term Debt |
0
|
0
|
20
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
4
|
3
|
22
|
18
|
20
|
34
|
47
|
46
|
|
| Other Current Liabilities |
10
|
14
|
5
|
6
|
6
|
8
|
14
|
9
|
|
| Total Current Liabilities |
56
|
65
|
131
|
152
|
155
|
165
|
154
|
159
|
|
| Long-Term Debt |
416
|
388
|
454
|
348
|
374
|
418
|
422
|
356
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
|
| Other Liabilities |
4
|
7
|
2
|
2
|
2
|
4
|
6
|
7
|
|
| Total Liabilities |
475
N/A
|
459
-3%
|
586
+28%
|
502
-14%
|
531
+6%
|
588
+11%
|
584
-1%
|
523
-10%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
10
|
10
|
10
|
10
|
10
|
|
| Retained Earnings |
44
|
16
|
59
|
138
|
311
|
382
|
348
|
350
|
|
| Additional Paid In Capital |
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
4
|
8
|
12
|
3
|
7
|
12
|
11
|
7
|
|
| Total Equity |
29
N/A
|
8
+71%
|
71
N/A
|
151
+114%
|
328
+118%
|
404
+23%
|
368
-9%
|
366
0%
|
|
| Total Liabilities & Equity |
446
N/A
|
450
+1%
|
657
+46%
|
653
-1%
|
859
+32%
|
993
+16%
|
952
-4%
|
890
-7%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
1 000
|
1 000
|
1 000
|
1 000
|
1 000
|
1 001
|
961
|
964
|
|